<DOC>
	<DOCNO>NCT02670135</DOCNO>
	<brief_summary>This single center , double blind , randomize , control trial . Qualified subject enrol randomize either one two study group : ) use 0.3 % triclosan/copolymer/fluoride dentifrice twice daily - b ) use match control dentifrice ( copolymer/fluoride/no triclosan ) twice daily .</brief_summary>
	<brief_title>Clinical Investigation Effects Colgate Total Toothpaste Compared Matching Placebo Periodontal Disease Systemic Inflammatory Markers</brief_title>
	<detailed_description>The objective study comparatively evaluate effect Colgate Total® toothpaste triclosan ( commercially sell Israel ) triclosan-free match placebo toothpaste marker inflammation bloodstream correlate finding periodontal disease status oral cavity , determine parameter assess . Periodontal parameter ( periodontal pocket dept ( PPD ) , Clinical Attachment loss ( CAL ) ) assess baseline 2 , 6 12 month product use . Peripheral blood sample draw subject baseline 2 , 6 12 month evaluate effect tooth brush systemic inflammatory marker ( CRP , PGE2 , IL-1β , TNF-α ) .</detailed_description>
	<mesh_term>Periodontal Diseases</mesh_term>
	<mesh_term>Gingival Diseases</mesh_term>
	<mesh_term>Sodium Fluoride</mesh_term>
	<mesh_term>Fluorides</mesh_term>
	<mesh_term>Listerine</mesh_term>
	<mesh_term>Triclosan</mesh_term>
	<criteria>1 . Subject male females 18 50 year old . 2 . Availability 12 month duration clinical research study . 3 . Subject able willing follow study procedure instruction . 4 . Subject read , understood sign informed consent form . 5 . Subject present least 20 natural teeth functional dentition ( exclude third molar ) . 6 . Initial probe pocket depth &gt; 4mm least one tooth/quadrant . 7 . Good general health . 8 . Subjects willing disclose information medication . 1 . Subject concomitant periodontal therapy 6 month prior enrollment . 2 . Subject orthodontic appliance . 3 . Subject chronically treat ( i.e . two week ) medication know affect inflammation periodontal status within one month first examination* . 4 . Subject treat antibiotic within 3 month prior enrollment . 5 . Subject necessitate antibiotic prophylaxis . 6 . Subject active infectious disease ( hepatitis , human immunodeficiency virus Tuberculosis ) subject immunocompromised determined Investigator* . 7 . Subject know allergy oral care product ingredients oral care product . 8 . Subject gross oral pathology , include widespread caries chronic neglect , extensive restoration , preexist gross plaque calculus , soft hard tissue tumor oral cavity ( determined examiner ) . 9 . Subject diagnose aggressive periodontitis acute necrotizing ulcerative gingivitis . 10 . Participation clinical study test panel within one month prior entry study . 11 . Subject pregnant point enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>